Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/4818Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Di Leo, A. | - |
| dc.contributor.author | Bleiberg, H. | - |
| dc.contributor.author | BUYSE, Marc | - |
| dc.date.accessioned | 2007-12-20T15:52:57Z | - |
| dc.date.available | 2007-12-20T15:52:57Z | - |
| dc.date.issued | 2003 | - |
| dc.identifier.citation | Journal of clinical oncology, 21(10). p. 2045-2047 | - |
| dc.identifier.uri | http://hdl.handle.net/1942/4818 | - |
| dc.language.iso | en | - |
| dc.publisher | AMER SOC CLINICAL ONCOLOGY | - |
| dc.title | Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer | - |
| dc.type | Journal Contribution | - |
| dc.identifier.epage | 2047 | - |
| dc.identifier.issue | 10 | - |
| dc.identifier.spage | 2045 | - |
| dc.identifier.volume | 21 | - |
| local.bibliographicCitation.jcat | A1 | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Article | - |
| dc.bibliographicCitation.oldjcat | A1 | - |
| dc.identifier.isi | 000182903400024 | - |
| dc.identifier.url | http://jco.ascopubs.org/cgi/content/full/21/10/2045-a | - |
| item.fullcitation | Di Leo, A.; Bleiberg, H. & BUYSE, Marc (2003) Overall survival is not a realistic endpoint for clinical trials in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer. In: Journal of clinical oncology, 21(10). p. 2045-2047. | - |
| item.accessRights | Closed Access | - |
| item.fulltext | No Fulltext | - |
| item.contributor | Di Leo, A. | - |
| item.contributor | Bleiberg, H. | - |
| item.contributor | BUYSE, Marc | - |
| Appears in Collections: | Research publications | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.